801748--3/21/2006--HEMACARE_CORP

related topics

{cost, operation, labor}

{regulation, government, change}

{product, liability, claim}

{stock, price, share}

{cost, regulation, environmental}

{personnel, key, retain}

{acquisition, growth, future}

{stock, price, operating}

{customer, product, revenue}

{capital, credit, financial}

{tax, income, asset}

{product, candidate, development}

{operation, natural, condition}

{provision, law, control}

{control, financial, internal}

Changes in demand for blood products could affect profitability Declining blood donations could affect profitability Market prices may not rise as costs increase which could reduce profitability Competition may cause a loss of customers and an increase in costs and impact profitability Operations depend on obtaining the services of qualified professionals and competition for their services is strong Heavily regulated industry could increase operating costs Decrease in reimbursement rates may affect profitability Lease for a major production facility has expired and if the Company needs to vacate it may be unable to locate an alternative facility thereby disrupting business Targeted partner blood drives involve higher collection costs Not-For-Profit status gives advantages to competitors since they are exempt from taxes Reliance on relatively few vendors for significant supplies and services could affect the Company s ability to operate Limited access to insurance could affect ability to defend against possible claims Potential adverse effect from changes in the healthcare industry, including consolidations, could affect access to customers Future technological developments, including the development of synthetic substitutes for blood products, could jeopardize business Potential inability to meet future capital needs could affect plans to finance future expansion Ability to attract, retain and motivate management and other skilled employees Product safety and product liability could provide exposure to claims and litigation Environmental risks could cause the Company to incur substantial costs to maintain compliance Business interruption due to terrorism and increased security measures in response to terrorism Articles of Incorporation and Rights Plan could delay or prevent an acquisition or sale of HemaCare Quarterly revenue and operating results may fluctuate in future periods, and the Company may fail to meet investor expectations Stocks traded on the OTC Bulletin Board are subject to greater market risks than those of exchange-traded and Nasdaq stocks since they are less liquid Stock price could be volatile Future sales of equity securities could dilute the Company s common stock Evaluation of internal control and remediation of potential problems will be costly and time consuming and could expose weaknesses in financial reporting Evaluation and consideration of strategic alternatives may distract management from reacting appropriately to business challenges and lead to reduced profitability

Full 10-K form ▸

801748--3/21/2006--HEMACARE_CORP_/CA/